Pramiracetam

Pramiracetam

Gene therapy
Clinical data
Routes of administration	Oral
Physiological data
Legal status
Legal status	Unscheduled (US)
Pharmacokinetic data
Identifiers
IUPAC name N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
PubChem Template:Abbreviation	51712
Chemical and physical data
Formula	C14H27N3O2
Molar mass	269.383 g/mol
3D model (JSmol)	Interactive image
SMILES CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C

Pramiracetam is a nootropic drug derived from piracetam, and is more potent (i.e. lower dosage is used). It belongs to the racetam family of nootropics.

Pramiracetam was developed by Parke-Davis based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade name Neupramir or Pramistar.

External links

• James South, Nootropics - Reviewing The Smart-Drugs
• The Cognitive Enhancement Research Institute